Company profile
UK company SC629589, incorporated on 7 May 2019.
Biomage: Single cell RNA-seq data analysis with Cellenics
Cellenics platform is an end-to-end tool, which allows you to perform single cell RNA-seq data processing, multiple sample data integration, visualisation, differential gene expression analysis and produce publication-quality figures.
Company number SC629589
Reference milestones and recent Companies House filing stream events.
GAZ2 | Transaction MzUzNTQ3MTU2NWFkaXF6a2N4 | Paper/PDF filed
Published 29 Jul 2026 22:52
Company registered at Companies House
Biomage develops a cloud-based analytics platform for RNA sequencing data.
Biomage is a biotech software company behind the Biomage Single Cell Platform. The Biomage Single Cell platform turns vast sequencing data sets into meaningful biology. Researchers studying cancer, cardiovascular health and developmental biology will use the platform to make discoveries about complex biological systems.
We have received funding for incubation of the startup at Harvard Medical School in Boston, Massachusetts. All co-founders in the business will relocate to Boston to work on the company starting on the 31st of April supervised by Prof. Peter Kharchenko. The funding received is from the Blavatnik Foundation and will allow for the employment of 4 full-time people for the business incubation period of 2 years.
